Levine DA - Search Results

1

OncoKB: A Precision Oncology Knowledge Base.

Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, Rudolph JE, Yaeger R, Soumerai T, Nissan MH, Chang MT, Chandarlapaty S, Traina TA, Paik PK, Ho AL, Hantash FM, Grupe A, Baxi SS, Callahan MK, Snyder A, Chi P, Danila D, Gounder M, Harding JJ, Hellmann MD, Iyer G, Janjigian Y, Kaley T, Levine DA, Lowery M, Omuro A, Postow MA, Rathkopf D, Shoushtari AN, Shukla N, Voss M, Paraiso E, Zehir A, Berger MF, Taylor BS, Saltz LB, Riely GJ, Ladanyi M, Hyman DM, Baselga J, Sabbatini P, Solit DB, Schultz N. Chakravarty D, et al. Among authors: levine da. JCO Precis Oncol. 2017 Jul;2017:PO.17.00011. doi: 10.1200/PO.17.00011. Epub 2017 May 16. JCO Precis Oncol. 2017. PMID: 28890946 Free PMC article.

2

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.

Diefenbach CS, Shah Z, Iasonos A, Barakat RR, Levine DA, Aghajanian C, Sabbatini P, Hensley ML, Konner J, Tew W, Spriggs D, Fleisher M, Thaler H, Dupont J. Diefenbach CS, et al. Among authors: levine da. Gynecol Oncol. 2007 Feb;104(2):435-42. doi: 10.1016/j.ygyno.2006.08.028. Epub 2006 Oct 4. Gynecol Oncol. 2007. PMID: 17023034

3

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

Levine D, Park K, Juretzka M, Esch J, Hensley M, Aghajanian C, Lewin S, Konner J, Derosa F, Spriggs D, Iasonos A, Sabbatini P. Levine D, et al. Cancer. 2007 Dec 1;110(11):2448-56. doi: 10.1002/cncr.23072. Cancer. 2007. PMID: 17918264 Free article. Clinical Trial.

4

Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma.

Eisenhauer EL, Sonoda Y, Levine DA, Abu-Rustum NR, Gemignani ML, Sabbatini PJ, Barakat RR, Chi DS. Eisenhauer EL, et al. Among authors: levine da. Am J Obstet Gynecol. 2008 Feb;198(2):213.e1-7. doi: 10.1016/j.ajog.2007.07.003. Am J Obstet Gynecol. 2008. PMID: 18226627

5

Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.

Zivanovic O, Barakat RR, Sabbatini PJ, Brown CL, Konner JA, Aghajanian CA, Abu-Rustum NR, Levine DA. Zivanovic O, et al. Among authors: levine da. Cancer. 2008 Jun 15;112(12):2690-7. doi: 10.1002/cncr.23485. Cancer. 2008. PMID: 18428210 Free article.

6

Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.

Kehoe SM, Williams NL, Yakubu R, Levine DA, Chi DS, Sabbatini PJ, Aghajanian CA, Barakat RR, Abu-Rustum NR. Kehoe SM, et al. Among authors: levine da. Gynecol Oncol. 2009 May;113(2):228-32. doi: 10.1016/j.ygyno.2009.01.016. Epub 2009 Feb 28. Gynecol Oncol. 2009. PMID: 19254808

7

Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.

Zivanovic O, Sima CS, Iasonos A, Bell-McGuinn KM, Sabbatini PJ, Leitao MM, Levine DA, Gardner GJ, Barakat RR, Chi DS. Zivanovic O, et al. Among authors: levine da. Gynecol Oncol. 2009 Nov;115(2):209-14. doi: 10.1016/j.ygyno.2009.06.038. Epub 2009 Aug 7. Gynecol Oncol. 2009. PMID: 19664812 Free PMC article.

8

Genomic and biological characterization of exon 4 KRAS mutations in human cancer.

Janakiraman M, Vakiani E, Zeng Z, Pratilas CA, Taylor BS, Chitale D, Halilovic E, Wilson M, Huberman K, Ricarte Filho JC, Persaud Y, Levine DA, Fagin JA, Jhanwar SC, Mariadason JM, Lash A, Ladanyi M, Saltz LB, Heguy A, Paty PB, Solit DB. Janakiraman M, et al. Among authors: levine da. Cancer Res. 2010 Jul 15;70(14):5901-11. doi: 10.1158/0008-5472.CAN-10-0192. Epub 2010 Jun 22. Cancer Res. 2010. PMID: 20570890 Free PMC article.

9

Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.

Mankoo PK, Shen R, Schultz N, Levine DA, Sander C. Mankoo PK, et al. Among authors: levine da. PLoS One. 2011;6(11):e24709. doi: 10.1371/journal.pone.0024709. Epub 2011 Nov 3. PLoS One. 2011. PMID: 22073136 Free PMC article.

10

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.

Hyman DM, Zhou Q, Iasonos A, Grisham RN, Arnold AG, Phillips MF, Bhatia J, Levine DA, Aghajanian C, Offit K, Barakat RR, Spriggs DR, Kauff ND. Hyman DM, et al. Among authors: levine da. Cancer. 2012 Aug 1;118(15):3703-9. doi: 10.1002/cncr.26655. Epub 2011 Dec 2. Cancer. 2012. PMID: 22139894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

591 results

Search Page